Cargando…
Identification and characterization of ANO9 in stage II and III colorectal carcinoma
Background and Objectives: The precise role and potential underlying mechanisms of anoctamin 9 (ANO9) remain largely unknown. This study aims to characterize the role and oncogenic mechanisms of ANO9 in stage II and III colorectal cancer (CRC). Methods: We examined the expression of ANO9 in colorect...
Autores principales: | Li, Chunxiang, Cai, Sanjun, Wang, Xishan, Jiang, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745729/ https://www.ncbi.nlm.nih.gov/pubmed/26317553 |
Ejemplares similares
-
Hypomethylation-Associated Up-Regulation of TCF3 Expression and Recurrence in Stage II and III Colorectal Cancer
por: Li, Chunxiang, et al.
Publicado: (2014) -
Vitamin D Status and Survival in Stage II-III Colorectal Cancer
por: Bao, Yichao, et al.
Publicado: (2020) -
Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum
por: Li, Qingguo, et al.
Publicado: (2017) -
GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer
por: Zhao, Zhixun, et al.
Publicado: (2018) -
Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma
por: Liu, Gang, et al.
Publicado: (2017)